International Clinical Trial: An exploratory, non randomized controlled clinical study to evaluate the efficacy of traracillin in the first-line treatment of patients with limited stage small cell lung cancer receiving chemotherapy and sequential radiotherapy

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123265) titled 'An exploratory, non randomized controlled clinical study to evaluate the efficacy of traracillin in the first-line treatment of patients with limited stage small cell lung cancer receiving chemotherapy and sequential radiotherapy' on April 23.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Liaoning Cancer Hospital

Condition: Limited Stage small cell lung cancer

Intervention: Test group:Cladribine Chemotherapy Radiotherapy Cladribine: 240 mg/m2, intravenous infusion over 30 minutes, to be completed within 4 hours before chemotherapy Etoposide: 100 mg/m2, intravenous inf...